[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-ANNX":3,"homepage-market-summary":30,"stock-news-ANNX":173},{"ticker":4,"date":5,"profile":6,"quote":14},"ANNX","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9},"Annexon, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.","93","Brisbane, CA",{"close":15,"open":16,"high":17,"low":18,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},4.19,4.21,4.265,4.105,4.12,0.07,1.7,4013669.332298,21620,4.1795,38.0099983,1.285,1158494.260562534,7.9,1556,{"status":31,"indices":32,"watchlist":77,"sectors":99,"benchmarks":155},"success",[33,41,48,55,62,69],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":39,"sparkline":61,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":67,"is_up":39,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":75,"sparkline":76,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,false,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":39,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":39,"sparkline":91,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":39,"sparkline":98,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":39},"Technology","XLK",1.01,199.81,{"name":106,"etf":107,"change":108,"price":109,"is_up":39},"Financials","XLF",0.06,53.49,{"name":111,"etf":112,"change":113,"price":114,"is_up":75},"Healthcare","XLV",-0.01,166.18,{"name":116,"etf":117,"change":118,"price":119,"is_up":39},"Consumer Cycl","XLY",1.13,110.04,{"name":121,"etf":122,"change":123,"price":124,"is_up":39},"Consumer Staples","XLP",0.25,80.53,{"name":126,"etf":127,"change":128,"price":129,"is_up":39},"Energy","XLE",0.4,62.95,{"name":131,"etf":132,"change":133,"price":134,"is_up":39},"Industrials","XLI",0.78,169.95,{"name":136,"etf":137,"change":138,"price":139,"is_up":39},"Materials","XLB",0.66,48.86,{"name":141,"etf":142,"change":143,"price":144,"is_up":39},"Real Estate","XLRE",0.32,40.81,{"name":146,"etf":147,"change":148,"price":149,"is_up":39},"Utilities","XLU",0.38,39.83,{"name":151,"etf":152,"change":153,"price":154,"is_up":39},"Comm Services","XLC",0.35,110.32,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":39},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":162,"name":163,"price":164,"change":90,"is_up":39},"QQQ","Invesco QQQ Trust",749.58,{"ticker":166,"name":167,"price":168,"change":53,"is_up":39},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":170,"name":171,"price":172,"change":67,"is_up":39},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":174,"articles":175},11,[176,182,188,194,200,206,212,217,223,228,234],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"More than 8 million people have an eye disease that can cause blindness. Annexon will present trial findings. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxPOF8tSmRKa01jd2Jqb3JaMDYwdkNUa2FBTzlwQ21lci1vTjc4NU05NklXX1kyRFlBSTBDMVItRXNuVmZ0SlBSV2RnWGNXNTlhdUdldVh6SUJ1dVlFOVh1cW5qRWVRcVlrbjdQcndYYzIxLWZiamRNYmw4OG1POTlMYTI1UnhaQjFkdm85Z0hqSG5iQXJITmZMXzlfT3RNRTVhRkdVXzBheDdVQUw5Q1l0RG10S1g1ZzhzQ0ZfMnQ2ZEk?oc=5","Thu, 24 Sep 2026 12:00:00 GMT","More than 8 million people have an eye disease that can cause blindness. Annexon will present trial findings. Stock Titan","Stock Titan",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"Annexon: Preserving Patient Function Is The Real Investment Opportunity (NASDAQ:ANNX) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxNaDZWemRvV3ZTUFRyNFJxMThwZ0lkbFJLZUNFeTZ0bWFQbFdNcHpBM2FYVl9zdWhSNUwwc2hRSDRzeFhNZmgxX1dKbzg5dDk2eC0zQU4zZmtNNHNBajdrbkZzQ252dy1tX2xjTmQyS2JfeHo3SHlCTkV2QllOaW9FVXBfUllmNzBTYnZkdjR2a0F6QXdKQ0J6M0VsUGJMQi1Pd0JpcHAxNC1uT0plQjRxaGRRZk9nSDlh?oc=5","Sun, 27 Sep 2026 09:50:56 GMT","Annexon: Preserving Patient Function Is The Real Investment Opportunity (NASDAQ:ANNX) Seeking Alpha","Seeking Alpha",{"title":189,"link":190,"pubDate":191,"description":192,"source":193},"ANNX Maintained by JP Morgan -- Price Target Raised to $15.00 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxPZmVkTEpjNXpSQi1IR3FfN2xUQ0VsMHZaY0w5MlY5M1dhdXA4cXJXZ21WZ042Nmd4c184OUM1QzM0TlBySTFpdEY1dHJMVHAyemU4aUcwclh3Qi1iWHdoYlJvb1lEMnlvU3U4eWVVSnk2QlczbEV5ZVdLWGpCYzZlcDk1RTFzVkZlZ3hfeU02TzR3Yk9nV2lzR09RQQ?oc=5","Wed, 30 Sep 2026 19:05:01 GMT","ANNX Maintained by JP Morgan -- Price Target Raised to $15.00 GuruFocus","GuruFocus",{"title":195,"link":196,"pubDate":197,"description":198,"source":199},"Insider Spends US$100k Buying More Shares In Annexon - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Sun, 27 Sep 2026 13:55:14 GMT","Insider Spends US$100k Buying More Shares In Annexon Simply Wall Street","Simply Wall Street",{"title":201,"link":202,"pubDate":203,"description":204,"source":205},"Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2wFBVV95cUxNMkZIUzJuVDVVLUFJa3NfX2FVS1FBM1NsODJwNV84WHY0VHB2bmZBMVdNakVnUThzQmxXVlFGZnhDQnAxdGZ6SUgxbFhWa3o3dWUtZTM0c0pHSDRtUnZqd2JQSHNacmFnSW42NXNfVEtIanNTUzRNTzlIWl9CY2ZrbHdJVDc4UlVvTzZjQURnOFFkMTlwTk52dnItMmxpOWh5TmRwaHJOYWs3UjZuQmV5VENYQUliY20xUTZaUC10RmEzemFJTE5ZX3laZ3pFMUdyUjZKV3Y5cDFsVXc?oc=5","Wed, 30 Sep 2026 09:44:00 GMT","Wall Street Analysts Are Bullish on Top Healthcare Picks The Globe and Mail","The Globe and Mail",{"title":207,"link":208,"pubDate":209,"description":210,"source":211},"J.P. Morgan Maintains Annexon(ANNX.US) With Buy Rating, Raises Target Price to $15 - Moomoo","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirAFBVV95cUxOb3Q0b1BEZHA4UUZTX2xRVzh1bkp3b1drOHF4ZnA1V1Ywb3BGc2RPcEh6dFd0WnU5Umh4THR2M19zbXRlOFJkMno5ek4zSVlMa0ZNN3hfSTdZT0pvUzBNX09SQWNJcTlFcWhEVnZVVG5mTnplTUlVRHViN1I1ZFEwWTIxbmhCSWRYMnpWTXV5cU0zbTBlTkNETUFUdjhPUEdteE1CR3RoZkY0aVFB?oc=5","Wed, 30 Sep 2026 11:31:00 GMT","J.P. Morgan Maintains Annexon(ANNX.US) With Buy Rating, Raises Target Price to $15 Moomoo","Moomoo",{"title":213,"link":214,"pubDate":215,"description":216,"source":181},"After buying shares at a $3.83 average, Annexon (ANNX) CEO Love Douglas holds 390,476 shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqAFBVV95cUxOQ1B2cHluZ3VoTDBLYUdVTTR1eWlidWI4eGdpSjVlWVlCZkpGeHhESmtTdTZVeWhPSE9HZFI0N0U5dUQzZzlxZXFMRVFheVNTTGNyaVREZkgtbXV6SVJQVldSN1Nzd3JnQTRXeVZTdzY5SThjSkdKa2xrclVZVS10TXloR3BaaE5vSnV2MVYzSVpNX0xEOTF2cHdydHFmLUdYTEZERHVsUlo?oc=5","Fri, 25 Sep 2026 20:29:41 GMT","After buying shares at a $3.83 average, Annexon (ANNX) CEO Love Douglas holds 390,476 shares. Stock Titan",{"title":218,"link":219,"pubDate":220,"description":221,"source":222},"JPMorgan raises Annexon Biosciences price target on trial data - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxPenlnZXJMSy1rQndwcGhjd2RaMlluY3ROTTFZY25IY3RrTkc1MkdURXoxTXpFVGtEcHJzUW1NNFUxMmI5dDF2RWNiY1JlTG95Znh0NTNfNm5LT1hVdUp0d2toVVNncVV4N2gzc0UtV3laMTlYYU1hcXVLYXAwa200eFNsSmEwS1pWSUFEUEQzd3g2MlQ5QmVFNS1pOWFNUzF4TFM2ZVRfd3RqeG1ldTRka05OOTM0eEdnWWc4d2tXNA?oc=5","Wed, 30 Sep 2026 14:23:22 GMT","JPMorgan raises Annexon Biosciences price target on trial data Investing.com","Investing.com",{"title":224,"link":225,"pubDate":226,"description":227,"source":193},"Annexon (ANNX) President and CEO Douglas Love Buys 26,065 Shares - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogFBVV95cUxQSC1tbnZNbUVCTVdER3NvSV93Y0RCbm9qRHBfLU9TVWVzNkVxZWhHdGxJT0lzVWNuQTB1WHIxbmlTSXNQXzdMcVZYU1Z0cmhNY24yNHB6LVpfUkJ0WkdTNHhEa0pKem9BZDJsNVB6NFpxaWZEU3k3MURzaGhqaG5BUzd2dkxUcWRzeUlLSFJJV1ZtZGZfU2p2a2FuMzlXVWFIVEE?oc=5","Fri, 25 Sep 2026 22:22:35 GMT","Annexon (ANNX) President and CEO Douglas Love Buys 26,065 Shares GuruFocus",{"title":229,"link":230,"pubDate":231,"description":232,"source":233},"Annexon (ANNX) Q2 2026 Earnings: Wider-Than-Expected Loss, Yet Shares Edge Higher - Share Repurchase Impact - siam.in","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxORXlPM3VOcGxHbGhJNE9oSU5MM0gzdkxELWNRUWZkaElHa004bnNONFZycWFnbFF3QXJVdXZQaWNFdU02Wk1fMTJxQUZsMHo0a3EwVXZuVWVtaEhMTUtacWxPaDFQUTdCYlNNWU5ETm5iRHJoRmhab0JxTmhQYzR1MWlxZXlTYnhFa05KaTJmQnhDLWdwZU0yUzV5ZjFSMGVGMWpURDJ0OVdGSWpmMFVfWGQ2MEl6RWt5ZVE?oc=5","Wed, 30 Sep 2026 20:34:43 GMT","Annexon (ANNX) Q2 2026 Earnings: Wider-Than-Expected Loss, Yet Shares Edge Higher - Share Repurchase Impact siam.in","siam.in",{"title":235,"link":236,"pubDate":237,"description":238,"source":239},"Annexon (ANNX) Ticks Up 1.44% to $4.23, Holding Firmly Above $4.02 Support - AI Trade Signals - dars.gov.et","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi5gFBVV95cUxQNkFnVm5sTDdVeTF1RzlKdGZOMUd6cFd3bmlwSjdtZWhOM1pFNlJtd2ZyYXVrQllNelNFNVVHbDJYbHlTeGwtMzMza3VUX3VzbEJuY0tZT1p3TmRqLU14QWUzeXlvQWJGMldpZGN6MHdwZFhKa1ZWencwbU9rVHliWnJ3ZUM3VWZORzBXN0VLYS1hSjlRRHNpRkRsTzcxOTFxVnJkMGpqMTV0Nzlrc2ZCRFJ4QTZJRW9nNWNhaGIzZm55cTdYRlJJSmZiUGtONGZrSjdnakoyVG0zRm5WRi0zRFgxcjMtQQ?oc=5","Sun, 20 Sep 2026 15:43:31 GMT","Annexon (ANNX) Ticks Up 1.44% to $4.23, Holding Firmly Above $4.02 Support - AI Trade Signals dars.gov.et","dars.gov.et"]